NorrDia Belgium bv

NorrDia Belgium bv manufactures devices primarily used in renal dialysis treatment. Their product lines include the Aquamax series, which appears to focus on solutions for fluid management in dialysis, and the Accusol line, likely designed to support precision in dialysis processes. These devices are tailored for clinical environments where accurate and reliable fluid handling is critical.

NorrDia Belgium bv is based in Belgium, which places its devices under the regulatory framework of the European Union. Since their products are listed in the EU’s eudamed database, they must comply with EU Medical Device Regulations (MDR) or the previous Medical Device Directive (MDD), depending on the device’s classification and market placement date. The EU’s centralized system ensures traceability and transparency for healthcare professionals and regulators.

NorrDia Belgium bv’s devices are listed in the eudamed database, the official EU registry for medical devices. This registry provides public access to information about devices authorized in the EU, including their classification, manufacturer details, and UDI (Unique Device Identifier) data. Listing in eudamed ensures compliance with EU requirements and allows healthcare providers to verify the legitimacy and classification of the devices before use.

NorrDia Belgium bv’s devices fall under EU Class IIb classification, which indicates a moderate to high risk level. Class IIb devices require rigorous pre-market evaluation to ensure their safety and performance, including clinical data and conformity assessments. This classification reflects the critical nature of their role in dialysis treatment, where precision and reliability are essential to patient care.

NorrDia Belgium bv emphasizes simplicity and reliability in their device design to address challenges in renal care environments. Dialysis treatments require consistent, error-free performance to avoid complications, so devices built with these principles help reduce operational complexity for healthcare providers. Their background in Gambro—an established player in renal care—suggests a focus on leveraging decades of expertise to deliver solutions that enhance treatment accuracy and patient outcomes.